Understanding Bilateral Pulmonary Embolism (Bilateral PE): This comprehensive guide covers diagnosis, clinical documentation, and medical coding for pulmonary emboli in both lungs. Learn about Bilateral PE symptoms, treatment, and the latest healthcare guidelines for accurate coding and documentation. Find information on pe bilateral, its impact on lung function, and resources for healthcare professionals.
Also known as
Pulmonary embolism
Blockage of an artery in the lungs, often due to a blood clot.
Other venous embolism and thrombosis
Covers venous embolisms and thrombosis not classified elsewhere.
Other pulmonary vascular diseases
Includes various other disorders affecting the blood vessels in the lungs.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the pulmonary embolism confirmed?
When to use each related code
| Description |
|---|
| Blood clots in both lungs. |
| Blood clot in one lung. |
| Suspected but unconfirmed PE. |
Coding for "bilateral" PE requires distinct documentation of emboli in BOTH lungs. Unilateral or unspecified documentation leads to inaccurate coding (e.g., I26.99 vs. I26.02).
A saddle PE (I26.03) is a specific type of bilateral PE. Accurate coding requires clear physician documentation to differentiate and avoid coding errors.
Distinguishing between acute (I26) and chronic (I27) PE is crucial for proper coding and reimbursement. Documentation must clearly specify the chronicity.
Q: How does the clinical presentation of bilateral pulmonary embolism differ from unilateral PE, and what specific signs should I look for in a suspected bilateral PE patient?
A: While both unilateral and bilateral pulmonary embolism (PE) can present with dyspnea, chest pain, and tachycardia, bilateral PE often presents with more severe symptoms due to increased obstruction of pulmonary vasculature. Specifically, clinicians should be highly suspicious of bilateral PE in patients presenting with acute onset severe dyspnea, hypoxemia disproportionate to the chest x-ray findings, signs of right heart strain (e.g., elevated jugular venous pressure, right ventricular heave), or syncope. The presence of these signs should prompt immediate further investigation, including a CT pulmonary angiography (CTPA) or ventilation/perfusion (V/Q) scan. Explore how risk stratification tools, such as the Wells Score or Geneva Score, can aid in assessing the probability of PE in these patients.
Q: What are the recommended anticoagulation treatment strategies for acute bilateral pulmonary embolism, and what factors should influence the choice between DOACs and LMWH/warfarin?
A: Current guidelines recommend direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, or edoxaban as the preferred initial treatment for most patients with acute bilateral pulmonary embolism, given their ease of administration and comparable efficacy to low molecular weight heparin (LMWH) followed by warfarin. However, factors that favor LMWH/warfarin over DOACs include severe renal impairment (creatinine clearance < 30 mL/min), active cancer, or patient inability to afford DOACs. For hemodynamically unstable patients with bilateral PE, thrombolytic therapy may be considered in consultation with a specialist. Consider implementing a structured follow-up plan to monitor treatment efficacy and potential bleeding complications. Learn more about the latest guidelines for PE management from reputable sources like the American College of Chest Physicians (CHEST).
Patient presents with acute onset of dyspnea and chest pain, suggestive of pulmonary embolism. Symptoms include shortness of breath, pleuritic chest pain, and increased heart rate. The patient reports no recent surgery or prolonged immobility, but does have a family history of thromboembolic disease. Physical examination reveals tachycardia and mild tachypnea. Lung auscultation reveals clear breath sounds bilaterally. D-dimer levels are elevated. Computed tomography angiography (CTA) of the chest demonstrates bilateral pulmonary emboli, confirming the diagnosis of bilateral pulmonary embolism. Differential diagnoses considered included pneumonia, myocardial infarction, and pleurisy. Given the patient's presentation and imaging findings, the diagnosis of bilateral PE is established. Treatment plan includes initiation of anticoagulation therapy with heparin, followed by transition to oral anticoagulants such as warfarin or a direct oral anticoagulant (DOAC). Patient education provided regarding risks, benefits, and potential side effects of anticoagulation. Follow-up appointment scheduled for monitoring of INR levels and assessment of treatment response. Prognosis for recovery is good with appropriate anticoagulation therapy. ICD-10 code I26.92, Pulmonary embolism without acute cor pulmonale, is assigned. CPT codes for the CTA chest and subsequent physician services will be documented appropriately for medical billing and coding purposes. Patient advised to return to the emergency department if symptoms worsen.